Molecular mechanisms of inflammation-induced carcinogenesis

Journal of Clinical Biochemistry and Nutrition

Volumn 39, Issue 3, 2006, Pages 103-113

  Okada, Futoshi ^a   Fujii, Junichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Inflammation

Indexed keywords

ASBESTOS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRRITANT AGENT; NITROGEN; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TOBACCO SMOKE;

AUTOIMMUNITY; BACTERIAL INFECTION; CANCER; CARCINOGENESIS; DNA METHYLATION; GENETIC ANALYSIS; GENOTOXICITY; HELICOBACTER PYLORI; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS VIRUS; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MOLECULAR BIOLOGY; OPISTHORCHIS; PARASITOSIS; PATHOGENICITY; PHAGOCYTE; REVIEW; RISK FACTOR; VIRUS INFECTION; WART VIRUS;

EID: 34248669004     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.39.103     Document Type: Review

References (99)

1. Global action against cancer-updated version. World Health Organization and International Union Against Cancer, pp. 12, 2005.
2. Stewart, B.W. and Kleihues, P.: World Cancer Report, IARC Press, Lyon, pp. 56-61, 2003.
3. Schmidt, A. and Weber, O.F.: In memoriam of Rudolf virchow: a historical retrospective including aspects of inflammation, infection and neoplasia. Contrib. Microbiol., 13, 1-15, 2006.
4. Prehn, R.T. and Lappe, M.A.: An immunostimulation theory of tumor development. Transplant. Rev., 7, 26-54, 1971.
5. Kuper, H., Adami, H.O., and Trichopoulos, D.: Infections as a major preventable cause of human cancer. J. Intern. Med., 248, 171-183, 2000.
6. Ohshima, H. and Bartsch, H.: Chronic infections and inflammatory processes as cancer risk factors; possible role of nitric oxide in carcinogenesis. Mutation Res., 305, 253-564, 1994.
7. Salama, N., Guillemin, K., McDaniel, T.K., Sherlock, G., Tompkins, L., and Falkow, S.: A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc. Natl. Acad. Sci. USA, 97, 14668-14673, 2000.
8. Covacci, A., Censini, S., Bugnoli, M., Petracca, R., Burroni, D., Macchia, G., Massone, A., Papini, E., Xiang, Z., Gigura, N., and Pappuoli, R.: Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA, 90, 5791-5795, 1993.
9. Harris, P.R., Mobley, H.L., Perez-Perez, G.I., Blaser, M.J., and Smith, P.D.: Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology, 111, 419-425, 1996.
10. Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., and Reeve, A.E.: E-cadherin germline mutations in familial gastric cancer. Nature, 392, 402-405, 1998.
11. Hatakeyama, M. and Higashi, H.: Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci., 96, 835-843, 2005.
12. Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M., and Hatakeyama, M.: SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science, 295, 683-686, 2002.
13. Mimuro, H., Suzuki, T., Tanaka, J., Asahi, M., Haas, R., and Sasakawa, C.: Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell, 10, 745-755, 2002.
14. Churin, Y., Al-Ghoul, L., Kepp, O., Meyer, T.F., Birchmeier, W., and Naumann, M.: Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell Biol., 161, 249-255, 2003.
15. Kozol, R., Domanowski, A., Jaszewski, R., Czanko, R., McCurdy, B., Prasad, M., Fromm, B., and Calzada, R.: Neutrophil chemotaxis in gastric mucosa: a signal-to-response comparison. Dig. Dis. Sci., 36, 1277-1280, 1991.
16. Nielsen, H. and Andersen, L.P.: Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leukocytes and monocytes. Gut, 33, 738-742, 1992.
17. Tatematsu, M., Tsukamoto, T., and Mizoshita, T.: Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in mongolian gerbils. Helicobacter, 10, 97-106, 2005.
18. Parkin, D.M., Srivatanakul, P., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiripong, S., L'Abbe, K.A., and Wild, C.P.: Liver cancer in Thailand. I.: A case-control study of cholangiocarcinoma. Int. J. Cancer, 48, 323-328, 1991.
19. Srivatanakul, P., Ohshima, H., Khlat, M., Parkin, M., Sukaryodhin, S., Brouet, I., and Bartsch, H.: Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int. J. Cancer, 48, 821-825, 1991.
20. Pinlaor, S., Ma, N., Hiraku, Y., Yongvanit, P., Semba, R., Oikawa, S., Murata, M., Sripa, B., Sithithaworn, P., and Kawanishi, S.: Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7, 8-dihydro-2′-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis, 25, 1535-1542, 2004.
21. Kantor, A.F., Hartge, P., Hoover, R.N., Narayana, A.S., Sullivan, J.W., and Fraumeni, J.F.Jr.: Urinary tract infection and risk of bladder cancer. Am. J. Epidemiol., 119, 510-515, 1984.
22. Hayashi, J., Aoki, H., Arakawa, Y., and Hino, O.: Hepatitis C virus and hepatocarcinogenesis. Intervirology, 42, 205-210, 1999.
23. Himeno, Y., Fukuda, Y., Hatanaka, M., and Imura, H.: Expression of oncogenes in human liver disease. Liver, 8, 208-212, 1988.
24. Hsu, I.C., Tokiwa, T., Bennett, W., Metcalf, R.A., Welsh, J.A., Sun, T., and Harris, C.C.: p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis, 14, 987-992, 1993.
25. Hagen, T.M., Huang, S., Curnutte, J., Fowler, P., Martinez, V., Wehr, C.M., Ames, B.N., and Chisari, F.V.: Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 91, 12808-12812, 1994.
26. Kato, J., Kobune, M., Nakamura, T., Kuroiwa, G., Takada, K., Takimoto, R., Sato, Y., Fujikawa, K., Takahashi, M., Takayama, T., Ikeda, T., and Niitsu, Y.: Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res., 61, 8697-8702, 2001.
27. Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., Snijders, P.J., Peto, J., Meijer, C.J., and Munoz, N.: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189, 12-19, 1999.
28. Longworth, M.S. and Laimins, L.A.: Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev., 68, 362-372, 2004.
29. Herrero, R., Castellsague, X., Pawlita, M., Lissowska, J., Kee, F., Balaram, P., Rajkumar, T., Sridhar, H., Rose, B., Pintos, J., Fernandez, L., Idris, A., Sanchez, M.J., Nieto, A., Talamini, R., Tavani, A., Bosch, F.X., Reidel, U., Snijders, P.J., Meijer, C.J., Viscidi, R., Munoz, N., and Franceschi, S.: Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst., 95, 1772-1783, 2003.
30. Hawley-Nelson, P., Vousden, K.H., Hubbert, N.L., Lowy, D.R., and Schiller, J.T.: HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J., 8, 3905-3910, 1989.
31. Munger, K., Phelps, W.C., Bubb, V., Howley, P.M., and Schlegel, R.: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63, 4417-4421, 1989.
32. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J., and Howley, P.M.: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136, 1990.
33. Ko, L. and Prives, C.: p53: puzzle and paradigm. Genes Dev., 10, 1054-1072, 1996.
34. Huibregtse, J.M., Scheffner, M., and Howley, P.M.: Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol., 13, 775-784, 1993.
35. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Itoh, H., Yutsudo, M., Ariga, H., and Inoue, M.: Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res., 28, 669-677, 2000.
36. Dyson, N., Howley, P.M., Munger, K., and Harlow, E.: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934-937, 1989.
37. Wang, J., Sampath, A., Raychaudhuri, P., and Bagchi, S.: Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells. Oncogene, 20, 4740-4749, 2001.
38. Levin, B.: Ulcerative colitis and colon cancer: biology and surveillance. J. Cell Biochem., 16G Suppl., 47-50, 1992.
39. Ekbom, A.: Risk of cancer in ulcerative colitis. J. Gastrointest. Surg., 2, 312-313, 1998.
40. Choi, P.M. and Zelig, M.P.: Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut, 35, 950-954, 1994.
41. Taams, L.S., Palmer, D.B., Akbar, A.N., Robinson, D.S., Brown, Z., and Hawrylowicz, C.M.: Regulatory T cells in human disease and their potential for therapeutic manipulation. Immunology, 118, 1-9, 2006.
42. + CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun., 71, 1755-1762, 2003.
43. Cabrera, R., Tu, Z., Xu, Y., Firpi, R.J., Rosen, H.R., Liu, C., and Nelson, D.R.: An immunomodulatory role for CD4(+) CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology, 40, 1062-1071, 2004.
44. Wolf, A.M., Wolf, D., Steurer, M., Gastl, G., Gunsilius, E., and Grubeck-Loebenstein, B.: Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res., 9, 606-612, 2003.
45. Asbestos, IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, IARC Press, Lyon, pp. 11-106, 1977.
46. Dhala, A., Pinsker, K., and Prezant, D.J.: Respiratory health consequences of environmental tobacco smoke. Med. Clin. North Am., 88, 1535-1552, xi 2004.
47. Hippeli, S., Dornisch, K., Kaiser, S., Drager, U., and Elstner, E.F.: Biological durability and oxidative potential of a stonewool mineral fibre compared to crocidolite asbestos fibres. Arch Toxicol., 71, 532-535, 1997.
48. Badwey, J.A. and Karnovsky, M.L.: Active oxygen species and the functions of phagocytic leukocytes. Annu. Rev. Biochem., 49, 695-726, 1980.
49. Yamashina, K., Miller, B.E., and Heppner, G.H.: Macrophage-induced induction of drug-resistance variants in a mouse mammary tumor cell line. Cancer Res., 46, 2396-2401, 1986.
50. Weitzman, S.A., Weitberg, A.B., Clark, E.P., and Stossel, T.P.: Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science, 227, 1231-1233, 1985.
51. Okada, F., Hosokawa, M., Hamada, J.I., Hasegawa, J., Kato, M., Mizutani, M., Ren, J., Takeichi, N., and Kobayashi, H.: Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge). Br. J. Cancer, 66, 635-639, 1992.
52. Tazawa, H., Okada, F., Kobayashi, T., Tada, M., Mori, Y., Une, Y., Sendo, F., Kobayashi, M., and Hosokawa, M.: Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: Implication of inflammation-associated carcinogenesis and tumor progression. Am. J. Pathol., 163, 2221-2232, 2003.
53. Okada, F., Kawaguchi, T., Habelhah, H., Kobayashi, T., Tazawa, H., Takeichi, N., Kitagawa, T., and Hosokawa, M.: Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice. Lab. Invest., 80, 1617-1628, 2000.
54. Hamada, J., Takeichi, N., Okada, F., Ren, J., Li, X., Hosokawa, M., and Kobayashi, H.: Progression of weakly malignant clone cells derived from rat mammary carcinoma by host cells reactive to plastic plates. Jpn. J. Cancer Res., 83, 483-490, 1992.
55. Boone, C.W., Takeichi, N., Eaton, S.D., and Paranjpe, M.: "Spontaneous" neoplastic transformation in vitro: a form of foreign body (smooth surface) tumorigenesis. Science, 204, 177-179, 1979.
56. Heppner, G.H. and Dorcey, L.: Macrophages and development of cancer, in Macrophages and Cancer, eds. By Heppner, G.H. and Fulton, A.M., CRC Press, London, pp. 197-208, 1988
57. Forrester, K., Ambs, S., Lupold, S.E., Kapust, R.B., Spillare, E.A., Weinberg, W.C., Felley-Bosco, E., Wang, X.W., Geller, D.A., Tzeng, E., Billiar, T.R., and Harris, C.C.: Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. USA, 93, 2442-2447, 1996.
58. Wink, D.A., Hanbauer, I., Grisham, M.B., Laval, F., Nims, R.W., Laval, J., Cook, J., Pacelli, R., Liebmann, J., Krishna, M., Ford, P.C., and Mitchell, J.B.: Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr. Top Cell. Regul., 34, 159-187, 1996.
59. Chen, C.J., Yu, M.W., and Liaw, Y.F.: Epidemiological characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol., 12, S294-S308, 1997.
60. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., and Harris, C.C.: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature, 350, 427-428, 1991.
61. Hussain, S.P., Aguilar, F., Amstad, P., and Cerutti, P.: Oxyradical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene, 9, 2277-2281, 1994.
62. Hofseth, L.J., Hussain, S.P., Wang, X.W., and Harris, C.C.: Hepatocellular cancer: molecular biology and genetics, in Gastrointestinal oncology: principles and practice. eds. By Kelsen, D.P., Daly, J.M., Kern, S.E., Levin, B., and Tepper, J.E., Lippincott, Williams & Wilkins, Hagerstown, pp. 539-558, 2002.
63. Hussain, S.P., Raja, K., Amstad, P.A., Sawyer, M., Trudel, L.J., Wogan, G.N., Hofseth, L.J., Shields, P.G., Billiar, T.R., Trautwein, C., Hohler, T., Galle, P.R., Phillips, D.H., Markin, R., Marrogi, A.J., and Harris, C.C.: Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc. Natl. Acad. Sci. USA, 97, 12770-12775, 2000.
64. Nair, J., Carmichael, P.L., Fernando, R.C., Phillips, D.H., Strain, A.J., and Bartsch, H.: Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis. Cancer Epidemiol. Biomarkers Prev., 7, 435-440, 1998.
65. Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Harrington, A.M., Shields, P.G., Felley-Bosco, E., Hussain, S.P., and Harris, C.C.: Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl. Cancer Inst., 91, 86-88, 1999.
66. Fujimoto, H., Sasaki, J., Matsumoto, M., Suga, M., Ando, Y., Iggo, R., Tada, M., Saya, H., and Ando, M.: Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma. Jpn. J. Cancer Res., 89, 696-702, 1998.
67. Tazawa, H., Tatemichi, M., Sawa, T., Gilibert, I., Ma, N., Hiraku, Y., Donehower, L.A., Ohgaki, H., Kawanishi, S., and Ohshima, H.: Oxidative and nitrative stress caused by subcutaneous implantation of a foreign body accelerate sarcoma development in Trp53+/- mice. Carcinogenesis, 2006, in press.
68. Karin, M.: Nuclear factor-kappaB in cancer development and progression. Nature, 441, 431-436, 2006.
69. Jones, P.A. and Laird, P.W.: Cancer epigenetics comes of age. Nat. Genet., 21, 163-167, 1999.
70. Jones, P.A. and Takai, D.: The role of DNA methylation in mammalian epigenetics. Science, 293, 1068-1070, 2001.
71. Issa, J.P.: CpG-island methylation in aging and cancer. Curr. Top Microbiol. Immunol., 249, 101-118, 2000.
72. Wolffe, A.P. and Matzke, M.A.: Epigenetics: regulation through repression. Science, 286, 481-486, 1999.
73. Ushijima, T. and Okochi-Takada, E.: Aberrant methylations in cancer cells: Where do they come from? Cancer Sci, 96, 206-211, 2005.
74. Kang, G.H., Lee, H.J., Hwang, K.S., Lee, S., Kim, J.H., and Kim, J.S.: Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am. J. Pathol., 163, 1551-1556, 2003.
75. Vallyathan, V., Shi, X., and Castranova, V.: Reactive oxygen species: their relation to pneumoconiosis and carcinogenesis. Environ. Health Perspect., 106, 1151-1155, 1998.
76. Belinsky, S.A., Snow, S.S., Nikula, K.J., Tellez, C.S., and Palmisano, W.A.: Aberrant CpG island methylation of the p16 (INK4a) and estrogen receptor genes in rat lung tumors induced by particulate carcinogens. Carcinogenesis, 23, 335-339, 2002.
77. Kim, D.H., Nelson, H.H., Wiencke, J.K., Zheng, S., Christiani, D.C., Wain, J.C., Mark, E.J., and Kelsey, K.T.: p16 (INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res., 61, 3419-3424, 2001.
78. Jang, T.J., Kim, D.I., Shin, Y.M., Chang, H.K., and Yang, C.H.: p16(INK4a) Promoter hypermethylation of non-tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy and chronic inflammation. Int. J. Cancer, 93, 629-634, 2001.
79. Osawa, T., Chong, J.M., Sudo, M., Sakuma, K., Uozaki, H., Shibahara, J., Nagai, H., Funata, N., and Fukayama, M.: Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma. Jpn. J. Cancer Res., 93, 1195-2000, 2002.
80. Kondo, Y., Kanai, Y., Sakamoto, M., Mizokami, M., Ueda, R., and Hirohashi, S.: Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis: A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology, 32, 970-979, 2000.
81. Narimatsu, T., Tamori, A., Koh, N., Kubo, S., Hirohashi, K., Yano, Y., Arakawa, T., Otani, S., and Nishiguchi, S.: p16 Promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection. Intervirology, 47, 26-31, 2004.
82. House, M.G., Wistuba, I.I., Argani, P., Guo, M., Schulick, R.D., Hruban, R.H., Herman, J.G., and Maitra, A.: Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer. Ann. Surg. Oncol., 10, 882-889, 2003.
83. Azarschab, P., Porschen, R., Gregor, M., Blin, N., and Holzmann, K.: Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Genes Chromosomes Cancer, 35, 121-126, 2002.
84. Matsumura, S., Oue, N., Ito, R., Nakayama, H., Kitadai, Y., Yokozaki, H., Chayama, K., and Yasui, W.: The promoter methylation status of the DNA repair gene O6-methylguanine-DNA methyltransferase in ulcerative colitis. Virchows Arch., 443, 518-523, 2003.
85. Hiroyasu, M., Ozeki, M., Kohda, H., Echizenya, M., Tanaka, T., Hiai, H., and Toyokuni, S.: Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am. J. Pathol., 160, 419-424, 2002.
86. Toyokuni, S. and Akatsuka, S.: What has been learned from the studies of oxidative stress-induced carcinogenesis: proposal of the concept of oxygenomics. J. Clin. Biochem. Nutr., 39, 3-10, 2006.
87. Ames, B.N., Shigenaga, M., and Hagen, T.M.: Oxidants, antioxidants, and the degenerative disease of aging. Proc. Natl. Acad. Sci. USA, 90, 7915-7922, 1993.
88. de Vera, M.E., Shapiro, R.A., Nussler, A.K., Mudgett, J.S., Simmons, R.L., Morris, S.M. Jr., Billiar, T.R., and Geller, D.A.: Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc. Natl. Acad. Sci. USA, 93, 1054-1059, 1996.
89. Ohshima, H., Sawa, T., and Akaike, T.: 8-Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid. Redox Signal., 8, 1033-1045, 2006.
90. Akaike, T., Okamoto, S., Sawa, T., Yoshitake, J., Tamura, F., Ichimori, K., Miyazaki, K., Sasamoto, K., and Maeda, H.: 8-nitroguanosine formation in viral pneumonia and its implication for pathogenesis. Proc. Natl. Acad. Sci. USA, 100, 685-690, 2003.
91. Sawa, T., Akaike, T., Ichimori, K., Akuta, T., Kaneko, K., Nakayama, H., Stuehr, D.J., and Maeda, H.: Superoxide generation mediated by 8-nitroguanosine, a highly redox-active nucleic acid derivative. Biochem. Biophys. Res. Commun., 311, 300-306, 2003.
92. Pinlaor, S., Yongvanit, P., Hiraku, Y., Ma, N., Semba, R., Oikawa, S., Murata, M., Sripa, B., Sithithaworn, P., and Kawanishi, S.: 8-nitroguanine formation in the liver of hamsters infected with Opisthorchis viverrini. Biochem. Biophys. Res. Commun., 309, 567-571, 2003.
93. Ma, N., Adachi, Y., Hiraku, Y., Horiki, N., Horiike, S., Imoto, I., Pinlaor, S., Murata, M., Semba, R., and Kawanishi, S.: Accumulation of 8-nitroguanine in human gastric epithelium induced by Helicobacter pylori infection. Biochem. Biophys. Res. Commun., 319, 506-510, 2004.
94. Horiike, S., Kawanishi, S., Kaito, M., Ma, N., Tanaka, H., Fujita, N., Iwasa, M., Kobayashi, Y., Hiraku, Y., Oikawa, S., Murata, M., Wang, J., Semba, R., Watanabe, S., and Adachi, Y.: Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C., J. Hepatol., 43, 403-410, 2005.
95. Ding, X., Hiraku, Y., Ma, N., Kato, T., Saito, K., Nagahama, M., Semba, R., Kuribayashi, K., and Kawanishi, S.: Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci., 96, 157-163, 2005.
96. Chaiyarit, P., Ma, N, Hiraku, Y., Pinlaor, S., Yongvanit, P., Jintakanon, D., Murata, M., Oikawa, S., and Kawanishi, S.: Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci., 96, 553-559, 2005.
97. Bos, J.L.: The ras gene family and human carcinogenesis. Mutat Res., 195, 255-271, 1988.
98. Takahashi, T., Nau, M.M., Chiba, I., Birrer, M.J., Rosenberg, R.K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A.F., and Minna, J.D.: p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491-494, 1989.
99. Kawanishi, S. and Hiraku, Y.: Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid. Redox Signal., 8, 1047-1058, 2006.